Research SummaryKey Findings

What research findings have Bronchogen had on bronchial epithelium and respiratory studies?

Bronchogen reduces inflammation and restores some epithelial and local immune function. Another study reports: it reduces epithelial remodeling and improves IgA secretion and inflammation-related indicators.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
i

Currently, 2 original studies related to the theme of this page have been selected. Fewer than 3, leaving a gap, no supplementation from other sources. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

Comparison of study design and results

Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.

LiteratureStudy subjects and designObservation and discoveryScope of Explanation
2017 · PMID 30199201Rat NO2-induced obstructive pulmonary diseaseBronchogen reduces inflammation and restores some epithelial and local immune function.2017 animal study.
2015 · PMID 26468022Obstructive lung disease in rats; Medication for one monthReduce epithelial remodeling and improve secretory IgA and inflammation-related markers.2015; Similar to later research teams and models, limited independence.

References

Animal Study2017 · Historical basic researchREF. 01

What are the changes in inflammation in obstructive lung pathology animal models?

Research Findings

Bronchogen reduces inflammation and restores some epithelial and local immune function.[1] ↗

Study Design

Rat NO2-induced obstructive pulmonary disease

Scope & Limitations

2017 animal study.

View the Article Title and Full Citation＋

[ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY].

Titova ON, Kuzubova NA, Lebedeva ES, Preobrazhenskaya TN, Surkova EA, Dvorakovskaya IV.

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · Volume and Issue Year 2017
First published 2017-02-01 · PMID 30199201
DOI not provided in the database

Published · Original ResearchPubMed ↗
Animal Study2015 · Historical basic researchREF. 02

What are the findings in bronchial epithelial morphology and local immunity research?

Research Findings

Reduce epithelial remodeling and improve secretory IgA and inflammation-related markers.[2] ↗

Study Design

Obstructive lung disease in rats; Medication for one month

Scope & Limitations

2015; Similar to later research teams and models, limited independence.

View the Article Title and Full Citation＋

Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology.

Kuzubova NA, Lebedeva ES, Dvorakovskaya IV, Surkova EA, Platonova IS, Titova ON.

Bulletin of Experimental Biology and Medicine · Volume and Issue Year 2015
First published 2015-09-01 · PMID 26468022
DOI 10.1007/s10517-015-3047-x

Published · Original ResearchPubMed ↗Journal Article ↗

Common issues and corresponding evidence

What research findings have Bronchogen had on bronchial epithelium and respiratory studies?＋

Bronchogen reduces inflammation and restores some epithelial and local immune function. Another study reports: it reduces epithelial remodeling and improves IgA secretion and inflammation-related indicators.[1] ↗ [2] ↗

Has Bronchogen epithelial repair research already been clinically verified?＋

No. The selected data comes from obstructive pulmonary disease animal models, which are close to the study system, and cannot be considered as independent successful human clinical replication.[1] ↗ [2] ↗

Bronchogen—these conclusions apply to which study populations?＋

Rat NO2-induced obstructive pulmonary disease; rat obstructive pulmonary disease; one month administration. 2017 animal study.[1] ↗ [2] ↗

Bronchogen

Return to catalog specifications and batch file verification entry.

↗